Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The insulin receptor β-subunit is the transmembrane and intracellular portion of the insulin receptor, a prototypical receptor tyrosine kinase that mediates insulin signaling in target cells[6][7][9][10]. The β-subunit is essential for signal transduction, containing the tyrosine kinase domain that becomes activated upon insulin binding to the extracellular alpha subunit[6][7][8][9][10]. The insulin receptor is a heterotetrameric protein comprising two alpha (α) subunits and two beta (β) subunits. The α-subunit is entirely extracellular and responsible for insulin binding, while the β-subunit spans the membrane and contains both transmembrane and intracellular portions[7][9][10]. The intracellular segment of the β-subunit harbors the receptor’s tyrosine kinase activity, critical for propagating insulin’s effects[6][7][10]. Upon insulin binding to the α-subunit, the β-subunit undergoes autophosphorylation, initiating downstream signaling cascades such as glucose uptake, glycogen synthesis, and inhibition of glucose production[6][7][8].
Activation/agonism: Insulin or agonists bind the extracellular α-subunit, triggering autophosphorylation of the β-subunit’s cytoplasmic kinase domain and downstream signaling. Tyrosine kinase inhibition: Experimental approaches in research settings
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin receptor β-subunit (IR β-subunit).